Valade N, Decailliot F, Rébufat Y, Heurtematte Y, Duvaldestin P, Stéphan F
Unité de Réanimation chirurgicale et traumatologique, Service d'Anesthésie-Réanimation, AP-HP Hôpital Henri Mondor, and Université Paris XII 94000, Créteil, France.
Br J Anaesth. 2005 Jan;94(1):18-23. doi: 10.1093/bja/aeh286. Epub 2004 Oct 14.
Our aim was to assess the occurrence, aetiology, and clinical significance of a platelet count greater than 600 x 10(3)/mm(3) in trauma patients.
All trauma patients admitted to the intensive care unit (ICU) during a 13-month period were prospectively studied. Platelet counts were performed daily. We recorded the patient's age, sex, nature of trauma, severity of illness scores, episodes of infections in the ICU, acute lung injury, bleeding, and thromboembolic events. Patients with thrombocytosis were also followed during their hospital stay and 1 month after hospital discharge.
A total of 176 patients were included. Thrombocytosis developed in 36 patients (20.4%) at a mean (sd) time of 14.0 (4.0) days and the platelet count normalized 35.0 (13.0) days after admission to the ICU. All patients with thrombocytosis had one or more possible predisposing conditions before the occurrence of thrombocytosis: nosocomial infection occurred in 30 patients (83%), acute lung injury in 17 (47%), bleeding in 27 (75%), and administration of cathecholamines in 24 (67%). Three venous thromboembolic complications occurred in the ICU (1.7%) and one during follow-up. Only one patient presented thrombocytosis at the time of diagnosis. Despite the fact that patients with thrombocytosis had a greater severity of illness, the ICU mortality was comparable among patients with and without thrombocytosis (8 vs 14%, P=0.34).
Reactive thrombocytosis is a common finding after severe trauma and was found to be associated with a better survival than predicted by severity of illness score. Unless additional risk factors are present, reactive thrombocytosis is not associated with an increased risk of thromboembolic events.
我们的目的是评估创伤患者血小板计数大于600×10³/mm³的发生率、病因及临床意义。
对13个月期间入住重症监护病房(ICU)的所有创伤患者进行前瞻性研究。每天检测血小板计数。我们记录了患者的年龄、性别、创伤性质、疾病严重程度评分、ICU内感染发作情况、急性肺损伤、出血及血栓栓塞事件。对血小板增多症患者在住院期间及出院后1个月进行随访。
共纳入176例患者。36例患者(20.4%)出现血小板增多症,平均(标准差)时间为14.0(4.0)天,血小板计数在入住ICU后35.0(13.0)天恢复正常。所有血小板增多症患者在血小板增多症发生前均有一个或多个可能的诱发因素:30例患者(83%)发生医院感染,17例(47%)发生急性肺损伤,27例(75%)出血,24例(67%)使用儿茶酚胺。ICU内发生3例静脉血栓栓塞并发症(1.7%),随访期间发生1例。仅1例患者在诊断时出现血小板增多症。尽管血小板增多症患者的疾病严重程度更高,但血小板增多症患者与无血小板增多症患者的ICU死亡率相当(8%对14%,P = 0.34)。
反应性血小板增多症是严重创伤后的常见表现,且发现其与比疾病严重程度评分预测更好的生存率相关。除非存在其他危险因素,反应性血小板增多症与血栓栓塞事件风险增加无关。